ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $38,000 | – | 23,000 | +11286.1% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 202 | -76.8% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 872 | +30.1% | 0.00% | – |
| Q3 2015 | $1,000 | -96.6% | 670 | +15.5% | 0.00% | -100.0% |
| Q2 2015 | $29,000 | -31.0% | 580 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $42,000 | -90.6% | 580 | -99.3% | 0.00% | -88.9% |
| Q3 2014 | $449,000 | -35.2% | 80,600 | -0.4% | 0.01% | -30.8% |
| Q4 2013 | $693,000 | +317.5% | 80,960 | +588.0% | 0.01% | +333.3% |
| Q3 2013 | $166,000 | +232.0% | 11,768 | +246.5% | 0.00% | +200.0% |
| Q2 2013 | $50,000 | – | 3,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |